Dagode, Salvacion L.

HRN: 12-71-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
CEFTAZIDIME 1GM (VIAL)
05/07/2026
05/13/2026
IV
1g
Q8h
Febrile Neutropenia
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Febrile Neutropenia    Compliance to guidelines: Compliant To Guidelines